Therapy News and Research

RSS

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden NHS Foundation Trust.

28 Sep 2019

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.

28 Sep 2019

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).

27 Sep 2019

Study: Nearly half of cancer patients who enter a tobacco treatment program quit smoking

In the largest smoking cessation study of cancer patients to date, researchers from The University of Texas MD Anderson Cancer Center found that comprehensive tobacco treatment can help cancer patients successfully quit and abstain from smoking.

27 Sep 2019

Novel nanogels could precisely deliver therapeutic treatments to cancer patients

Researchers at The University of Texas at Austin have developed new guidelines for fabricating nanoscale gel materials, or nanogels, that can deliver numerous therapeutic treatments to treat cancer in a precise manner.

27 Sep 2019

African American children respond differently to step-up therapies for asthma

African Americans suffer asthma more often and more severely than Caucasian patients. However, clinical trials that have shaped treatment guidelines have included few African Americans.

27 Sep 2019

Tobacco treatment program in an oncologic setting could foster smoking cessation

A tobacco treatment program delivered at a cancer center had average seven-day smoking abstinence rates of about 45% at three- and six-month follow-ups and nearly 44% at the nine-month follow-up, and those rates didn't differ between patients with and without cancer.

27 Sep 2019

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective.

27 Sep 2019

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.

27 Sep 2019

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

New data from the randomized, placebo-controlled TWILIGHT trial found that compared to ticagrelor plus aspirin, ticagrelor monotherapy reduces bleeding events without increasing the risk of death, myocardial infarction, or stroke in high-risk patients who have undergone successful percutaneous coronary intervention and completed three months of dual antiplatelet therapy.

27 Sep 2019

Stem cells lost in freezer malfunction: hospital apologizes and offers full support

Los Angeles hospital has apologized and offered full support after stem cells perish in fridge malfunction.

27 Sep 2019

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.

27 Sep 2019

Lumpectomy is less invasive surgery and requires no hospitalization, shows study

It is well established that breast conservation, which involves the removal of a breast cancer along with a small rim of normal breast tissue around it and is followed by radiation therapy, is at least as effective as mastectomy (removal of the whole breast) for the treatment of early breast cancer.

27 Sep 2019

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic awards.

27 Sep 2019

Therapy News and Research

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Study: Nearly half of cancer patients who enter a tobacco treatment program quit smoking

Novel nanogels could precisely deliver therapeutic treatments to cancer patients

African American children respond differently to step-up therapies for asthma

Tobacco treatment program in an oncologic setting could foster smoking cessation

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

Stem cells lost in freezer malfunction: hospital apologizes and offers full support

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Lumpectomy is less invasive surgery and requires no hospitalization, shows study

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

High-risk heart patients may not require long-term aspirin use after stent placement

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Partial, whole breast radiation after lumpectomy yield similar cosmetic outcomes

AI accurately predicts radiation therapy side effects for patients with head and neck cancers

High-dose radiation effective for men whose prostate cancer has spread, trial shows

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News